Early efficacy results in the Alumites study: A randomized, controlled, multicenter, phase IV study with house dust mites subcutaneous immunotherapy. Two months symptoms and medication scores
Servizos
Servizos
Data de publicación
2015Título da revista
Allergy
Tipo de contido
Publicación de congreso
